26 products were found matching your search for antipsychotic in 2 shops:

Relying upon the best-selling third edition of Stahl's Essential Psychopharmacology, Dr. Stephen M. Stahl has revised chapters covering antipsychotics and mood stabilizers for this third edition of Antipsychotics and Mood Stabilizers. More than one-third longer than the previous edition, Antipsychotics and Mood Stabilizers is essential reading for professionals treating psychosis and students learning the mechanisms of drug reactions. This updated edition includes advances in neurobiology and recent clinical developments to explain the concepts underlying drug treatment of psychiatric disorders. The fully revised text is complemented by many new illustrations and enhanced to reflect new knowledge and topics not covered in the previous edition. Intended as a primer text covering all aspects of treatment for psychosis and related conditions, this concise volume can nevertheless be read cover to cover by experts and novices alike.

Target Audience: This activity was designed for healthcare professionals, including psychiatrists, neurologists, primary care physicians, nurses, pharmacists, and others who treat patients with psychiatric conditions. Overview: This book aims to visually explain the underlying pathophysiology of schizophrenia, give an overview of the receptor profiles of conventional and atypical antipsychotics and provide information on best treatment approaches. The book is divided into 5 chapters for ease of reading and referencing. Chapter 1 Neurobiology of Schizophrenia focuses on the known and hypothetical causes underlying the pathophysiology of schizophrenia. Chapter 2 Three Classes of Antipsychotics is divided into three parts and focuses on conventional D2 antagonists, 5HT2A/D2 antagonists, and D2 partial agonists. Chapter 3 Side Effects of Antipsychotics: Metabolic Issues and Sedation explains the importance of monitoring patients initiated on antipsychotic medication. Chapter 4 17 Individual Antipsychotic Drugs describes each antipsychotic medication currently available in terms of side effects profile, dosing tips, and drug interactions. Finally Chapter 5 Schizophrenia Pharmacy and Switching Strategies presents different ways to treat the various symptoms of schizophrenia and describes ways to switch between different antipsychotic agents. The visual component of this minibook is designed to allow for the reader to easily grasp concepts. Learning Objectives: After completing this activity, participants should be better able to: * Describe the hypothetical neurobiology of schizophrenia * Understand the complex pharmacology of antipsychotics * Recognize how different drug properties affect the various symptoms of schizophrenia * Recognize that side effects are linked to the drug's receptor profile * Develop an understanding of the best treatment practices and switching methods for schizophrenia

Acceptable/Fair condition. Book is worn, but the pages are complete, and the text is legible. Has wear to binding and pages, may be ex-library. 2.2

Book is in NEW condition. 0.99

Unread book in perfect condition.

New Book. Shipped From Uk. This Book Is Printed On Demand. Established Seller Since 2000.

This spin-off from Stephen M. Stahl's new, completely revised, and fully updated sixth edition of the Prescriber's Guide covers the most important drugs in use today for treating patients suffering from psychotic illness. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.

The Stahl's Illustrated books are a series of pocket-sized, mid-priced, themed volumes. They distil theoretical information from the Essential Psychopharmacology volume and combine this with practical data from the Prescriber's Guide. They are illustration heavy and designed to encourage speedy learning of both concepts and applications. The visual learner will find that these books make the concepts easier to master and the non-visual learner will appreciate the clear shortened text on complex psychopharmacological concepts. This new edition emphasises the impact antipsychotic medications are now known to have in the treatment of mania and depression, as well as in the management of psychosis. The Stahl's Illustrated series appeals to the widest possible audience of mental health professionals, and not just those with expertise in psychopharmacology.

In response to rapid developments in psychopharmacology, this is a spin-off from Stephen M. Stahl's new, completely revised and updated third edition of his much-acclaimed Prescriber's Guide. It covers the most important drugs in use today for psychosis and mood stabilization. In full color throughout, and with four or more pages for each of the antipsychotic drugs, Stephen M. Stahl distills his great expertise into a pragmatic formulary that gives all the information a prescriber needs to treat patients effectively. Each drug is covered in five categories: general therapeutics, dosing and use, side effects, special populations, and pearls. Target icons appear next to key categories for each drug so that the prescriber can go easily and instantly to the information needed. Several indices are included, listing drugs by name (generic and international) and use. In addition, Dr. Stahl indicates which drugs have FDA approval and also gives the FDA Use-in-Pregnancy Ratings.

The Stahl's Illustrated books are a series of pocket-sized, mid-priced, themed volumes. They distil theoretical information from the Essential Psychopharmacology volume and combine this with practical data from the Prescriber's Guide. They are illustration heavy and designed to encourage speedy learning of both concepts and applications. The visual learner will find that these books make the concepts easier to master and the non-visual learner will appreciate the clear shortened text on complex psychopharmacological concepts. This new edition emphasises the impact antipsychotic medications are now known to have in the treatment of mania and depression, as well as in the management of psychosis. The Stahl's Illustrated series appeals to the widest possible audience of mental health professionals, and not just those with expertise in psychopharmacology.

In response to rapid developments in psychopharmacology, this is a spin-off from Stephen M. Stahl's new, completely revised and updated third edition of his much-acclaimed Prescriber's Guide. It covers the most important drugs in use today for psychosis and mood stabilization. In full color throughout, and with four or more pages for each of the antipsychotic drugs, Stephen M. Stahl distills his great expertise into a pragmatic formulary that gives all the information a prescriber needs to treat patients effectively. Each drug is covered in five categories: general therapeutics, dosing and use, side effects, special populations, and pearls. Target icons appear next to key categories for each drug so that the prescriber can go easily and instantly to the information needed. Several indices are included, listing drugs by name (generic and international) and use. In addition, Dr. Stahl indicates which drugs have FDA approval and also gives the FDA Use-in-Pregnancy Ratings.

This spin-off from Stephen M. Stahl's new, completely revised, and fully updated sixth edition of the Prescriber's Guide covers the most important drugs in use today for treating patients suffering from psychotic illness. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.

This book exposes the skyrocketing rate of antipsychotic drug prescriptions for children, identifies grave dangers when children's mental health care is driven by market forces, describes effective therapeutic care for children typically prescribed antipsychotics, and explains how to navigate a drug-fueled mental health system.· A chapter on effective parenting coauthored by a leading parenting expert, Laura Berk· Contributions by noted medical journalist Robert Whitaker, author of Anatomy of an Epidemic· Information on legal issues by Harvard-educated lawyer Jim Gottstein· Insights from former pharmaceutical industry insider, Gwen Olsen· An examination of community approaches to children's mental health care by internationally known psychologist Stuart Shanker

In response to the rapid developments in pscyhopharmacology, this is a spin-off from Stephen Stahl's new completely revised and updated edition of his much acclaimed Prescriber's Guide. It covers the 20 most important drugs in use today for psychosis and mood stabilization. From a review of the first Prescriber's Guide: ' ... The clinical tips and pearls that are found in each entry are invaluable - not only are dosing guidelines provided, but also the author's educated and respected opinion regarding potential advantages and disadvantages of each drug. The book's major strength is its readability and user friendliness. The art of psychopharmacology is finally given the space it deserves. ...This guidebook is an excellent source of information for the art of prescribing psychotropic medications and belongs in every clinician's library.' The Annals of Pharmacotherapy

Item in very good condition! Textbooks may not include supplemental items i.e. CDs, access codes etc.

This book overturns the idea that psychiatric drugs work by correcting chemical imbalance and analyzes the professional, commercial and political vested interests that have shaped this view. It provides a comprehensive critique of research on drugs including antidepressants, antipsychotics and mood stabilizers.

Vinyl LP pressing. After a severe mental breakdown, Kyle Bates of Portland, Oregon's Drowse was prescribed a plethora of antipsychotic drugs. Several unmedicated years later, anxiety resurfaced and he turned to Klonopin and alcohol-it was during this time that he wrote and recorded this second full-length album, Cold Air, marked by fanatical self-exploration and expansive detuned instrumentation.

Bipolar disorder (BPD) is a mood disorder that is characterized by periods of pathologic mood elevation (mania or hypomania). Many studies have proved that effective pharmacological treatment improves the quality of life in patients suffering with BPD. Various classes of antipsychotics and antiepileptics have been used in the treatment of BPD like sodium valproate (SVA), carbamazepine (CBZ), olanzapine (OLZ), risperidone etc. Despite the introduction of many new mood stabilizing medications and a continually advancing understanding of their individual strengths and weaknesses, selecting the best possible treatment for each individual patient remains a significant challenge for general practitioners and psychiatrists. Response and remission are key goals in the management of BPD, mania. There are very few literatures related to the direct head to head comparison of SVA and OLZ in bipolar affective disorder, mania and this book presents a new study. Therefore an attempt was made primarily to compare the efficacy of two mood stabilizers- SVA and OLZ using the Young Mania Rating Scale (YMRS) as the scale for assessment.

Schizophrenia has been and still is one of the most misunderstood and difficult-to-treat mental illnesses. Prior to the creation of antipsychotic medications in the 1950s, the only available treatments were frequently dangerous, and of questionable efficacy.By the 1960s, new medications had virtually replaced the old therapies, creating a revolution in the treatment of mental illness. It was thought that people with schizophrenia would be able to live independently in their communities, returning to hospitals only briefly to have a medication regimen adjusted or reinstituted. This period of hope did not last as patients began to experience disturbing side effects and the medications were found to be less effective than originally thought. What led doctors to embrace the new drug treatments so quickly? Did a rush to de-institutionalization give doctors, patients, and the general public false and dangerous hopes? Could this happen today?Sheldon Gelman looks at the manner in which psychiatrists have evaluated, interpreted, and prescribed antipsychotic drugs since their inception from the 1950s to the present. Gelman argues that hospitals were being emptied not because patients were "cured", but rather because of the changing ways society came to view disease, drugs, and scientific remedies. As we approach the fiftieth anniversary of the discovery of antipsychotic drugs, Gelman's book provides a provocative, timely examination of how and why medical treatments evolve.

Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.